Rosenberg Noah L. 4
4 · Travere Therapeutics, Inc. · Filed Feb 3, 2021
Insider Transaction Report
Form 4
Rosenberg Noah L.
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-02-03$28.91/sh−563$16,276→ 44,094 total - Sale
Common Stock
2021-02-03$28.91/sh−1,250$36,138→ 44,657 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units.
- [F2]The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.